MEDIPRINT OPHTHALMICS Trademark

Trademark Overview


On Friday, June 4, 2021, a trademark application was filed for MEDIPRINT OPHTHALMICS with the United States Patent and Trademark Office. The USPTO has given the MEDIPRINT OPHTHALMICS trademark a serial number of 90755523. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 11, 2024. This trademark is owned by MediPrint Ophthalmics, Inc.. The MEDIPRINT OPHTHALMICS trademark is filed in the Pharmaceutical Products category with the following description:

Contact lens drug delivery devices containing pharmaceutical preparations for the treatment or prevention of diseases and conditions that affect the eye, including but not limited to allergies, astigmatism, cataracts, diabetic retinopathy, dry eye, dry eye discomfort, eye infections, eye inflammation, glaucoma, keratonconus, macular degeneration, myopia, presbyopia, hyperopia, or a combination thereof
mediprint ophthalmics

General Information


Serial Number90755523
Word MarkMEDIPRINT OPHTHALMICS
Filing DateFriday, June 4, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 14, 2022

Trademark Statements


Description of MarkThe mark consists of san-serif lettering, wherein the term "MEDIPRINT" is depicted in bold lettering, and the stylized term "OPHTHALMICS" is depicted in regular type-face lettering. The letters "M" and "P" within the "MEDIPRINT" term are capitalized, and the letter "O" in the "OPHTHALMICS" term is situated within three concentric abstract circles. The concentric circles are depicted in a series of bubbles that transition in graduated boldness, size and weight.
Goods and ServicesContact lens drug delivery devices containing pharmaceutical preparations for the treatment or prevention of diseases and conditions that affect the eye, including but not limited to allergies, astigmatism, cataracts, diabetic retinopathy, dry eye, dry eye discomfort, eye infections, eye inflammation, glaucoma, keratonconus, macular degeneration, myopia, presbyopia, hyperopia, or a combination thereof
Disclaimer with Predetermined Text"OPHTHALMICS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 27, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMediPrint Ophthalmics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92131

Party NameMediPrint Ophthalmics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92131

Trademark Events


Event DateEvent Description
Monday, March 11, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 11, 2024ABANDONMENT - NO USE STATEMENT FILED
Wednesday, August 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 31, 2023SOU EXTENSION 2 GRANTED
Monday, July 31, 2023SOU EXTENSION 2 FILED
Monday, July 31, 2023SOU TEAS EXTENSION RECEIVED
Saturday, February 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 9, 2023SOU EXTENSION 1 GRANTED
Thursday, February 9, 2023SOU EXTENSION 1 FILED
Thursday, February 9, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, August 9, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 14, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 14, 2022PUBLISHED FOR OPPOSITION
Wednesday, May 25, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 12, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, May 9, 2022ASSIGNED TO LIE
Friday, May 6, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 4, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 4, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 4, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 4, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 4, 2022NON-FINAL ACTION E-MAILED
Friday, March 4, 2022NON-FINAL ACTION WRITTEN
Sunday, February 20, 2022ASSIGNED TO EXAMINER
Saturday, August 28, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, August 27, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 8, 2021NEW APPLICATION ENTERED